Similarly, high LHCGR expression was associated with higher PFS (HR 0.78; 95% CI 0.67–0.9, p < 0.0001, Figure 4a) and OS (HR 0.84; 95% CI 0.73–0.97, p = 0.018, Figure 4b) in all ovarian cancers and was linked with higher OS in patients with high-grade ovarian cancer (HR 0.82; 95% CI 0.7–0.96, p = 0.014, Figure 4d). This evidence concerns the gene LHCGR and ovarian cancer.